Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy ...
An iPSC manufacturing strategy for cell therapies drops the cost of goods sold to about $5,000 per dose, down from $115,000 per dose for autologous therapeutics and $40,000 per dose for allogeneic ...
A scalable, standardized platform to produce consistent, high-quality extracellular vesicles (EVs) from induced mesenchymal stem cells (MSCs) was developed recently by researchers at Allife Medicine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results